Embol-X U.S. launch
This article was originally published in The Gray Sheet
Executive Summary
185-patient study at Goethe Universitat in Frankfurt shows that Embol-X reduces cerebral injury 74% in high-risk patients compared to procedures without the filter, Edwards notes in materials for U.S. launch of aortic embolic protection device, announced Aug. 20. Edwards acquired the device through its $10 mil. purchase of Embol-X, Inc. in May (1"The Gray Sheet" May 5, 2003, p. 24). Embol-X is the only aortic embolic protection device approved in the U.S. for use during cardiac surgery, the company claims...